➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKinsey
Boehringer Ingelheim
McKesson
Medtronic
AstraZeneca
Moodys

Last Updated: February 28, 2021

DrugPatentWatch Database Preview

NEOMYCIN SULFATE-POLYMYXIN B SULFATE-HYDROCORTISONE Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Which patents cover Neomycin Sulfate-polymyxin B Sulfate-hydrocortisone, and what generic alternatives are available?

Neomycin Sulfate-polymyxin B Sulfate-hydrocortisone is a drug marketed by Pharmafair and is included in two NDAs.

The generic ingredient in NEOMYCIN SULFATE-POLYMYXIN B SULFATE-HYDROCORTISONE is hydrocortisone; neomycin sulfate; polymyxin b sulfate. There are sixty-seven drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the hydrocortisone; neomycin sulfate; polymyxin b sulfate profile page.

Summary for NEOMYCIN SULFATE-POLYMYXIN B SULFATE-HYDROCORTISONE
Drug patent expirations by year for NEOMYCIN SULFATE-POLYMYXIN B SULFATE-HYDROCORTISONE

US Patents and Regulatory Information for NEOMYCIN SULFATE-POLYMYXIN B SULFATE-HYDROCORTISONE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmafair NEOMYCIN SULFATE-POLYMYXIN B SULFATE-HYDROCORTISONE hydrocortisone; neomycin sulfate; polymyxin b sulfate SOLUTION/DROPS;OTIC 062394-001 Sep 29, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Pharmafair NEOMYCIN SULFATE-POLYMYXIN B SULFATE-HYDROCORTISONE hydrocortisone; neomycin sulfate; polymyxin b sulfate SUSPENSION/DROPS;OPHTHALMIC 062623-001 Sep 24, 1985 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
McKinsey
Baxter
AstraZeneca
Medtronic
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.